Abstinence Reinforcement Therapy (ART) for Rural Veteran Smokers
Completed · Not applicable
Conditions studied: Veteran, Smoking Cessation
In brief
The primary goal of the current study is to evaluate the effectiveness of a combined tele-health and contingency management (CM) intervention that investigators are calling Abstinence Reinforcement Therapy (ART). Proposed is a comparative effectiveness trial with a two-group design in which 310 Veteran smokers will be randomized to either: ABSTINENCE REINFORCEMENT THERAPY (ART) a proactive tele-health intervention that combines guideline based cognitive-behavioral telephone counseling (TC), a tele-medicine clinic for access to nicotine replacement (NRT), and intensive behavioral therapy through mobile contingency management. TELE-HEALTH FOR SMOKING CESSATION a proactive tele-health intervention that will provide controls for therapist, medication, time and attention effects. The tele-health intervention provides the same guideline based cognitive-behavioral smoking cessation telephone counseling (TC), and tele-medicine clinic for access to NRT as in the ART intervention.
Key facts
- Study ID
- NCT01723163
- Run by
- VA Office of Research and Development
- People needed
- 310
- Starts
- 2013-11-21
- Expected to finish
- 2017-09-01
- Last updated by the study team
- 2019-03-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Enrolled in the Durham VA for ongoing care.
- Current smokers planning to quit smoking in the next 30 days.
You may not qualify if…
- Active diagnosis of psychosis documented in the medical record.
- Does not have access to a telephone.
- Severely impaired hearing or speech (Veterans must be able to respond to phone calls).
Where it is running
- Durham VA Medical Center, Durham, NC — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.